Cocrystal Pharma, Inc.
Price Action
Technical Summary
CONSOLIDATINGCocrystal Pharma, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 31), showing significant lag compared to the market leaders. Earnings growth of 26% provides fundamental context to the price action. Investors should exercise caution due to high volatility (79% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.02 | +0.89% | ABOVE |
| 50 SMA | $1.19 | -13.68% | BELOW |
| 100 SMA | $1.15 | -10.56% | BELOW |
| 150 SMA | $1.11 | -7.16% | BELOW |
| 200 SMA | $1.12 | -8.31% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is COCP in an uptrend right now?
COCP has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is COCP overbought or oversold?
COCP's RSI (14) is 42. The stock is in neutral territory, neither overbought nor oversold.
Is COCP outperforming the market?
COCP has a Relative Strength (RS) Rating of 31 out of 99. COCP is currently lagging the broader market.
Where is COCP in its 52-week range?
COCP is trading at $1.03, which is 39% of its 52-week high ($2.67) and 9% above its 52-week low ($0.86).
How volatile is COCP?
COCP has a Beta of 1.45 and 52-week volatility of 79%. It's more volatile than the S&P 500 - expect bigger swings.